Next Generation Cancer Diagnostics Market to Reflect a Holistic Expansion During 2018 to 2024: Grand View Research Inc.

San Francisco, 7 September 2018: The global next generation cancer diagnostics market is anticipated to reach USD 11.04 billion by 2024, according to a new report by Grand View Research, Inc. Key drivers for this vertical include rising advancement in genomics and proteomics-based research coupled with increasing prevalence of oncology disorders.

Rise in number of oncological research projects to elucidate tumorigenesis and the underlying mechanisms, consequently raising the demand for serial sampling, diagnosis, and therapeutic manipulation, is a growth rendering driver of this market.

Access Research Report of Next Generation Cancer Diagnostics Market@: www.grandviewresearch.com/industry-analysis/next-generation-cancer-diagnostics-market

Further Key Findings from the Study Suggest:

·       The qPCR & multiplexing segment captured the largest market share in 2015 owing to the presence of a wide product portfolio serving numerous applications in oncology R&D

·       Next generation sequencing services and solutions for oncology applications are anticipated to be the fastest growing segment

·       Oncology diagnostics in biomarker discovery is expected witness growth as it subsequently facilitates drug designing and identification of novel targets against tumors

·       On the basis of cancer type, this vertical is segmented into lung, breast, colorectal, cervical, and other forms of cancer

·       Research projects to establish the therapeutic index of anticancer cytotoxic drugs are one of the key factors responsible for expected growth

·        North America dominated the market with respect to revenue generation in 2014 due to concerted efforts directed toward the development of next generation sequencing technology and companion diagnostics in personalized medicine

·       Some of the key players contributing significantly to the next generation cancer diagnostics market are Novartis AG; Cepheid; Hoffman La Roche Ltd.; PerkinElmer, Inc.; Sysmex Corporation; Abbott; Thermo Fisher Scientific, Inc.; Koninklijke Philips N.V.; Agilent Technologies; Illumina, Inc.; Genomic Health, Inc.; Qiagen; Janssen Global Services, LLC; Hologic, Inc.; Myriad Genetics, Inc.; Almac Group; Opko Health, Inc.; and GE Healthcare.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the next generation cancer diagnostics market on the basis of technology, application, cancer type, function, and region:

Technology Outlook (Revenue, USD Million, 2013 - 2024)

·         Next Generation Sequencing

·         qPCR & Multiplexing

·         Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)

·         Protein Microarrays

·         DNA Microarrays

Application Outlook (Revenue, USD Million, 2013 - 2024)

·         Biomarker Development

·         CTC Analysis

·         Proteomic Analysis

·         Epigenetic Analysis

·         Genetic Analysis

Cancer Type Outlook (Revenue, USD Million, 2013 - 2024)

·         Lung Cancer

·         Breast Cancer

·         Colorectal Cancer

·         Cervical Cancer

·         Others

Function Outlook (Revenue, USD Million, 2013 - 2024)

·         Therapeutic Monitoring

·         Companion Diagnostics

·         Prognostics

·         Cancer Screening

·         Risk Analysis

Regional Outlook (Revenue, USD Million, 2013 - 2024)

·         North America

o    U.S

o    Canada

·         Europe

o    Germany

o    France

·         Asia Pacific

o    Japan

o    China

·         Latin America

o    Brazil

·         Middle East & Africa

o    South Africa

Access Press Release of Next Generation Cancer Diagnostics Market@: www.grandviewresearch.com/press-release/global-next-generation-cancer-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Impact of Existing and Emerging Critical Care Diagnostics Market Trends and Forecast 2013 – 2024: Grand View Research Inc.

San Francisco, 7 September 2018: The global critical care diagnostics market is expected to reach USD 1.29 billion by 2024, according to a new report by Grand View Research, Inc. The critical care diagnostics market is expected to grow at a lucrative rate in the next few years. The key factors supporting the industry’s growth comprise the rapid awareness and acknowledgment of these tests by physicians and patients, the rise in geriatric population and chronic health conditions, the employment of telehealth services in remote areas, and technological advancements. The increased cost of the molecular diagnostics and dearth of skilled labor are factors that are expected to hinder the growth of the industry.

The critical care diagnostics market by test type is categorized into routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious diseases, coagulation testing, and others. The microbial and infectious diseases test diagnostics segment is projected to grow at the highest rate with a CAGR of over 5% during the forecast period. For example, healthcare systems spend a substantial amount of resources in the collection and processing of blood cultures for the identification of pathogens.

Critical care diagnostic tests, such as the nucleic acid amplification test, allow clinicians to detect and identify organisms more rapidly and accurately and provide guidance to clinicians, who aspire to commence the appropriate antimicrobial therapy as fast as possible and terminate the use of avoidable drugs. The critical care diagnostic market by the end-user is categorized into operation rooms, emergency rooms, and ICU’s. The emergency rooms segment in the industry is anticipated to witness the highest growth rate during the forecast period.

Access Research Report of Critical Care Diagnostics Market@: www.grandviewresearch.com/industry-analysis/critical-care-diagnostics-market

Further key findings from the study suggest:

·       The Asia Pacific region is estimated to dominate the critical care market in terms of the highest growth rate, with a CAGR of around 9.1% during the forecast period. The large presence of geriatric population, increasing prevalence of chronic diseases, increase in the number of specialty hospitals in the Asia Pacific region, and improving healthcare services and infrastructures in rural areas are the factors fueling the market growth.

·       The immunoproteins diagnostic test segment is estimated to account for the largest share of the critical care diagnostic market by type. The rise in demand for rapid and accurate preventive healthcare services is one of the major factors driving this market growth.

·       On the basis of end-users, approximately 20% of acute-care patients get admitted into ICU’s, whereas nearly 58% get admitted into emergency rooms. The emergency rooms are expected to witness exponential growth with the highest CAGR during the forecast period. The recent rise in the patient demand for ER services is due to its ability to provide initial acute care diagnosis and treatment of critically ill patients.

·       Some major players in this industry include Abbott., Alere, Inc., Beckman-Coulter, Roche Diagnostics, and Becton Dickinson & Co., among others.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global critical care diagnostics market on the basis of test type, end-user, and region:

Global Critical Care Diagnostics Type Outlook (Revenue, USD Million, 2013 - 2024)

·         Routine and special chemistry

·         Flow cytometry

·         Hematology

·         Immunoproteins

·         Microbial and infectious diseases

·         Coagulation test

·         Others

Global Critical Care Diagnostics End-user Outlook (Revenue, USD Million, 2013 - 2024)

·         Operating rooms

·         Emergency rooms

·         Intensive care units

·         Others

Critical Care Diagnostics Regional Outlook (Revenue, USD Million, 2013 - 2024)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    China

o    India

·         Latin America

o    Mexico

o    Brazil

·         Middle East and Africa

o    South Africa

o    Saudi Arabia

Access Press Release of Critical Care Diagnostics Market@: www.grandviewresearch.com/press-release/global-critical-care-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Gene Expression Analysis Market to Make Great Impact Near in Future by 2025: Grand View Research Inc.

San Francisco, 7 September 2018: The global gene expression market is expected to reach USD 11.3 billion by 2025, according to a new report by Grand View Research, Inc. Globally rising demand for targeted molecular therapeutics coupled with rising adoption of precision medicine is anticipated to fuel market growth.

Understanding gene expression under different conditions as well as the effects it has on different metabolic activities has opened various vistas for the development of a novel generation of molecular therapeutics. Search for methods to manipulate the way a coding DNA is expressed as a cure to different conditions arising due to abnormally expressed genes is expected to drive market.

Target expression analysis and single cell analysis using low- to mid- plex techniques to identify smallest differences and correlations in gene expression. Novel products focusing on with improved efficiency and reliability are launched for smaller samples. Increased interest stem cell and gene therapy are projected to propel revenue generation for the market.

Emerging NGS technologies coupled with their drastically declining prices are anticipated to boost adoption of gene expression techniques. Furthermore, government support through initiatives such as Precision Medicine Initiative would encourage private investments in the sector leading to market growth.

Drug discovery and development was estimated with largest share owing to higher adoption in drug response testing for severs and complicated diseases such as all types of cancer, tuberculosis, cardiac conditions and rare genetic disorders. However, clinical diagnostic application is projected with fastest growth owing to rising demand for rapid and accurate diagnosis of complex diseases coupled with their higher incidence.

Rising demand for precision medicine, higher prevalence of genetic disorders, and rapid advances in biotechnology is attributive to largest contribution to revenue by North America. Owing to the presence of countries, witnessing rapid economic developments and demand for better health care solutions Asia Pacific is anticipated to witness the fastest growth.

Access Research Report of Gene Expression Analysis Market@: www.grandviewresearch.com/industry-analysis/gene-expression-analysis-market

Further key findings from the report suggest:

·       RNA expression dominated the market with respect to analysis technique as the increased interest of researchers has been observed to have been directed to understanding RNA activity to better understand its effects on diseases

·       As there are a high number of products available for low to mid-plexing of gene expression, the segment was observed to have accounted for the higher share

·       Rising focus on higher accuracy is anticipated to drive growth of high-plex techniques.

·       Moreover, increased focus on cancer genomic is anticipated to bolster growth

·       Introduction of improved data analytics & interpretation with high turnaround efficiency coupled with increase in incidences of target diseases are vital factor influencing R&D.

·       Substantial adoption of gene expression techniques the U.S. can be attributed for the largest share of North American market.

·       Asia Pacific is anticipated to witness a high growth rate due to the presence of initiatives by key market participants to enhance presence in these emerging economies due to the presence of untapped potential

·       Key players contributing in this market are Qiagen, Quest Diagnostics Incorporated, Illumina, Bio-Rad Laboratories, Oxford Gene Technology, TAKARA,Biocartis Group NV, MYRIAD GENETICS, INC.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global gene expression analysis market on the basis of process, product, capacity, technique, application, and region:

Process Outlook (Revenue, USD Million; 2014 - 2025)

·         Sample Collection

·         Purification

·         cDNA synthesis & conversion

·         PCR Analysis

·         Data analysis & interpretation

Product Outlook (Revenue, USD Million; 2014 - 2025)

·         Kits & Reagents

·         DNA Chips

·         Others

Capacity Outlook (Revenue, USD Million; 2014 - 2025)

·         Low- to Mid- Plex

·         High-Plex

Technique Category Outlook (Revenue, USD Million; 2014 - 2025)

·         RNA Expression

o    Northern Blotting

o    DNA Microarrays

o    PCR Techniques

o    RNA-Seq

·         Promoter Analysis

o    In vitro Transcription/Nuclear Run-On Assays

o    Gel Shift Assays

o    Chromatin Immunoprecipitation (ChIP)

·         Protein Expression & Posttranslational Modification Analysis

o    Western Blotting

o    2-D Gel Electrophoresis

o    Immunoassays

o    Mass Spectrometry

Application Outlook (Revenue, USD Million; 2014 - 2025)

·         Drug Discovery & Development

·         Clinical Diagnostics

·         Biotechnology & Microbiology

·         Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    Japan

o    China

·         Latin America

o    Brazil

·         Middle East and Africa (MEA)

o    South Africa

Access Press Release of Gene Expression Analysis Market@: www.grandviewresearch.com/press-release/global-gene-expression-analysis-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com